InvestorsHub Logo
Followers 48
Posts 9781
Boards Moderated 1
Alias Born 01/31/2008

Re: zzaatt post# 93619

Monday, 02/25/2019 3:15:30 PM

Monday, February 25, 2019 3:15:30 PM

Post# of 108192
In mid-2017, 248 new immunotherapies and vaccines were in clinical trials, and trials testing combinations of immunotherapies with other treatments such as chemotherapy numbered 765.

AMGN and pharmas must have seen other ways to turn cold tumor hot
Any ideas on what that may be?


tons of articles if you google it. Here's a good one:

https://blog.dana-farber.org/insight/2018/06/enhancing-immunotherapy-race-make-cold-tumors-hot/

What you realize is ADXS doesn't have anything that unique. Tons of competitors.

Which may explain why ADXS never seems to have Merck or MBY by the balls.


You have to ask yourself, "Do I feel lucky?" Well, do you short punk?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News